SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Elan Corporation, plc (ELN)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Ben Wa who wrote (1427)1/28/2002 11:07:48 PM
From: Harold Engstrom  Read Replies (1) of 10345
 
Good article. More transparency is better. Still, Elan has built an enormous pile of cash. It has a very good pipeline. It actually makes stuff and sells it. There is no danger that Elan is going to suddenly wake up without earnings. Its revenues are almost entirely product revenues. They are not subject to arbitrage errors. They do not ship their products to the Grand Caymans or Luxembourg and then receive them back again tax-free. They have significant equity holdings in other companies. Did I mention the $2B in the bank that compliments the $2B in annual revenue?

If we are lucky, we will get a few more days of this nonsense. Then, it will move back up to a $14B-$16B market cap.

Compare to Biogen. Elan has roughly the same EPS; has more cash; has more diversified product base; makes deals more easily; has more investments; has higher projected growth rate; has greater revenue. Has lower market cap.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext